|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/44 | |
| C07D 231/02 | |||
| C07D 401/04 | |||
| C07C 45/65 | |||
| C07C 47/56 |
| (11) | Patento numeris | 3454854 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17796828.6 |
| Europos patento paraiškos padavimo data | 2017-05-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/032104 |
| Data | 2017-05-11 |
| (87) | Numeris | WO 2017/197083 |
| Data | 2017-11-16 |
| (30) | Numeris | Data | Šalis |
| 201662335583 P | 2016-05-12 | US |
| (72) |
LI, Zhe, US
GUZ, Nathan, US
SHAO, Yiyang, US
COCUZ, Julieana, US
FRIESER, Markus, US
YIANNIKOUROS, George, Petros, US
LIAO, Liang, US
|
| (73) |
Global Blood Therapeutics, Inc.,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (54) | PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |
| PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |